286 related articles for article (PubMed ID: 31660582)
1. Circulating β cell-specific CD8
Yeo L; Pujol-Autonell I; Baptista R; Eichmann M; Kronenberg-Versteeg D; Heck S; Dolton G; Sewell AK; Härkönen T; Mikk ML; Toppari J; Veijola R; Knip M; Ilonen J; Peakman M
Clin Exp Immunol; 2020 Mar; 199(3):263-277. PubMed ID: 31660582
[TBL] [Abstract][Full Text] [Related]
2. Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells.
Kronenberg D; Knight RR; Estorninho M; Ellis RJ; Kester MG; de Ru A; Eichmann M; Huang GC; Powrie J; Dayan CM; Skowera A; van Veelen PA; Peakman M
Diabetes; 2012 Jul; 61(7):1752-9. PubMed ID: 22522618
[TBL] [Abstract][Full Text] [Related]
3. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity.
Abreu JR; Martina S; Verrijn Stuart AA; Fillié YE; Franken KL; Drijfhout JW; Roep BO
Clin Exp Immunol; 2012 Oct; 170(1):57-65. PubMed ID: 22943201
[TBL] [Abstract][Full Text] [Related]
4. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
[TBL] [Abstract][Full Text] [Related]
5. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological characteristics of preproinsulin-specific CD8+ T cells in subjects with juvenile-onset and adult-onset type 1 diabetes: A 1-year follow-up study.
Paul M; Badal D; Jacob N; Dayal D; Kumar R; Bhansali A; Bhadada SK; Sachdeva N
Pediatr Diabetes; 2018 Feb; 19(1):68-79. PubMed ID: 28488272
[TBL] [Abstract][Full Text] [Related]
7. Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
Mallone R; Scotto M; Janicki CN; James EA; Fitzgerald-Miller L; Wagner R; Gottlieb P; Thorpe J; Jospe N; Durinovic-Bellò I; Boitard C; Lou O; Dayan CM; Wong FS;
Diabetes Metab Res Rev; 2011 Nov; 27(8):720-6. PubMed ID: 22069251
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathways for Immune Recognition of Preproinsulin Signal Peptide in Type 1 Diabetes.
Kronenberg-Versteeg D; Eichmann M; Russell MA; de Ru A; Hehn B; Yusuf N; van Veelen PA; Richardson SJ; Morgan NG; Lemberg MK; Peakman M
Diabetes; 2018 Apr; 67(4):687-696. PubMed ID: 29343547
[TBL] [Abstract][Full Text] [Related]
9. Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and
Mishto M; Mansurkhodzhaev A; Rodriguez-Calvo T; Liepe J
Front Immunol; 2021; 12():656451. PubMed ID: 33936085
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.
Velthuis JH; Unger WW; Abreu JR; Duinkerken G; Franken K; Peakman M; Bakker AH; Reker-Hadrup S; Keymeulen B; Drijfhout JW; Schumacher TN; Roep BO
Diabetes; 2010 Jul; 59(7):1721-30. PubMed ID: 20357361
[TBL] [Abstract][Full Text] [Related]
11. Human islet T cells are highly reactive to preproinsulin in type 1 diabetes.
Anderson AM; Landry LG; Alkanani AA; Pyle L; Powers AC; Atkinson MA; Mathews CE; Roep BO; Michels AW; Nakayama M
Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34611019
[TBL] [Abstract][Full Text] [Related]
12. Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null mice.
Unger WW; Pearson T; Abreu JR; Laban S; van der Slik AR; der Kracht SM; Kester MG; Serreze DV; Shultz LD; Griffioen M; Drijfhout JW; Greiner DL; Roep BO
PLoS One; 2012; 7(11):e49213. PubMed ID: 23155466
[TBL] [Abstract][Full Text] [Related]
13. Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR.
van Lummel M; van Veelen PA; de Ru AH; Janssen GM; Pool J; Laban S; Joosten AM; Nikolic T; Drijfhout JW; Mearin ML; Aanstoot HJ; Peakman M; Roep BO
J Immunol; 2016 Apr; 196(8):3253-63. PubMed ID: 26944932
[TBL] [Abstract][Full Text] [Related]
14. Single insulin-specific CD8+ T cells show characteristic gene expression profiles in human type 1 diabetes.
Luce S; Lemonnier F; Briand JP; Coste J; Lahlou N; Muller S; Larger E; Rocha B; Mallone R; Boitard C
Diabetes; 2011 Dec; 60(12):3289-99. PubMed ID: 21998398
[TBL] [Abstract][Full Text] [Related]
15. HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexes.
Scotto M; Afonso G; Østerbye T; Larger E; Luce S; Raverdy C; Novelli G; Bruno G; Gonfroy-Leymarie C; Launay O; Lemonnier FA; Buus S; Carel JC; Boitard C; Mallone R
Diabetes; 2012 Oct; 61(10):2546-55. PubMed ID: 22997432
[TBL] [Abstract][Full Text] [Related]
16. CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.
Skowera A; Ellis RJ; Varela-Calviño R; Arif S; Huang GC; Van-Krinks C; Zaremba A; Rackham C; Allen JS; Tree TI; Zhao M; Dayan CM; Sewell AK; Unger WW; Drijfhout JW; Ossendorp F; Roep BO; Peakman M
J Clin Invest; 2008 Oct; 118(10):3390-402. PubMed ID: 18802479
[TBL] [Abstract][Full Text] [Related]
17. Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes.
Ouyang Q; Standifer NE; Qin H; Gottlieb P; Verchere CB; Nepom GT; Tan R; Panagiotopoulos C
Diabetes; 2006 Nov; 55(11):3068-74. PubMed ID: 17065344
[TBL] [Abstract][Full Text] [Related]
18. Conventional and Neo-antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors.
Gonzalez-Duque S; Azoury ME; Colli ML; Afonso G; Turatsinze JV; Nigi L; Lalanne AI; Sebastiani G; Carré A; Pinto S; Culina S; Corcos N; Bugliani M; Marchetti P; Armanet M; Diedisheim M; Kyewski B; Steinmetz LM; Buus S; You S; Dubois-Laforgue D; Larger E; Beressi JP; Bruno G; Dotta F; Scharfmann R; Eizirik DL; Verdier Y; Vinh J; Mallone R
Cell Metab; 2018 Dec; 28(6):946-960.e6. PubMed ID: 30078552
[TBL] [Abstract][Full Text] [Related]
19. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies.
Marttila J; Huttunen S; Vaarala O; Suzuki K; Elliott JF; Närvänen A; Knip M; Simell O; Ilonen J
J Autoimmun; 2008 Sep; 31(2):142-8. PubMed ID: 18565729
[TBL] [Abstract][Full Text] [Related]
20. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
Serreze DV; Niens M; Kulik J; DiLorenzo TP
Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
